Target intelligence / Profile preview

Immune system (MMRV vaccine-induced activation) (MMRV-IA)

Target
MMRV-IA
Molecular classification
Other
01

Overview

This target entry refers to the broad physiological activation of the host immune system elicited by the administration of live attenuated vaccines for measles, mumps, rubella, and varicella-zoster (MMRV). It is not a single molecular target but a complex biological process involving the coordinated response of the innate and adaptive immune systems. Upon vaccination, the attenuated viruses undergo limited replication, mimicking a natural infection to induce long-lasting humoral and cellular immunity, characterized by the production of neutralizing antibodies and memory T-cells (Source: CDC, 2021). Beyond pathogen-specific protection, live attenuated vaccines like MMRV are recognized for their ability to induce 'trained immunity.' This phenomenon involves epigenetic modifications in innate immune cells that enhance their responsiveness to subsequent, unrelated infections, potentially contributing to a reduction in overall childhood mortality (Source: WHO, 2014; Arts et al., 2018). Clinically, this activation is the primary mechanism for preventing the morbidity and mortality associated with these four viral diseases.

Other names
MMRV vaccine-induced immunityNon-specific effects of live vaccinesTrained immunity (MMRV)Indirect immune activation by live attenuated virusesMMRV-induced heterologous immunity
02

Mechanism of action

The mechanism involves the stimulation of various pattern recognition receptors (PRRs), such as Toll-like receptors (TLRs) and RIG-I-like receptors, by live attenuated viral components. This triggers the production of type I interferons and proinflammatory cytokines, leading to the maturation of antigen-presenting cells and the subsequent priming of adaptive B-cell and T-cell responses (Source: StatPearls, 2023). Additionally, these live vaccines induce 'trained immunity' through the epigenetic and metabolic reprogramming of innate immune cells, such as monocytes and natural killer cells, which provides non-specific, heterologous protection against unrelated pathogens (Source: Netea et al., Science, 2016).

03

Biological functions

Immune responseAdaptive immunityInnate immunityTrained immunityEpigenetic regulationCellular proliferation
04

Disease associations

InfectionMeaslesMumpsRubellaChickenpoxViral infection
05

Safety considerations

Risk of disseminated vaccine-strain infection in immunocompromised individualsIncreased risk of febrile seizures (particularly with the first dose of MMRV combination vaccine)Vaccine-associated systemic symptoms (fever, rash)Hypersensitivity reactions to vaccine components (e.g., gelatin, neomycin)Potential for secondary transmission of vaccine-strain varicella (rare)
06

Interacting drugs

Measles, Mumps, Rubella, and Varicella Virus Vaccine Live

4 more in the full profile.

07

Biomarkers

Measles-specific IgG antibody titerMumps-specific IgG antibody titerRubella-specific IgG antibody titerVaricella-zoster-specific IgG antibody titerInterferon-gamma (IFN-γ) productionT-cell proliferation index

Beyond the preview

Go deeper on Immune system (MMRV vaccine-induced activation) (MMRV-IA).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Immune system (MMRV vaccine-induced activation) (MMRV-IA).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call